Nanotechnology-based mucoadhesive and mucus-penetrating drug-delivery systems for transbuccal drug delivery

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front. Pharmacol. 12, doi: 10.3389/fphar.2021.618411 (2021) (Online).
  Google Scholar
• 2. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20(2), 101–124 (2021).
  Medline CASGoogle Scholar
• 3. Abramson A, Kirtane AR, Shi Y et al. Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections. Matter 5(3), 975–987 (2022).
  CASGoogle Scholar
• 4. Mazzinelli E, Favuzzi I, Arcovito A et al. Oral mucosa models to evaluate drug permeability. Pharmaceutics 15(5), 1559 (2023).
  Medline CASGoogle Scholar
• 5. Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin. Pharmacokinet. 41(9), 661–680 (2002).
  Medline CASGoogle Scholar
• 6. Lam JKW, Xu Y, Worsley A, Wong ICK. Oral transmucosal drug delivery for pediatric use. Adv. Drug. Deliv. Rev. 73, 50–62 (2014).
  Medline CASGoogle Scholar
• 7. Madhav NVS, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: a review. J. Control. Rel. 140(1), 2–11 (2009).
  Medline CASGoogle Scholar
• 8. Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J. Control. Rel. 153(2), 106–116 (2011).
  Medline CASGoogle Scholar
• 9. Hua S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Front. Pharmacol. 10, doi: 10.3389/fphar.2019.01328 (2019) (Online).
  Google Scholar
• 10. Shipp L, Liu F, Kerai-Varsani L, Okwuosa TC. Buccal films: a review of therapeutic opportunities, formulations and relevant evaluation approaches. J. Control. Rel. 352, 1071–1092 (2022). • Highlights mucoadhesive buccal films.
  Medline CASGoogle Scholar
• 11. Al-Dhubiab BE, Nair AB, Kumria R, Attimarad M, Harsha S. Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir. Colloids Surf. B Biointerfaces 136, 878–884 (2015).
  Medline CASGoogle Scholar
• 12. Abd El Azim H, Nafee N, Ramadan A, Khalafallah N. Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins. Int. J. Pharm. 488(1–2), 78–85 (2015).
  MedlineGoogle Scholar
• 13. Kamimori GH, Karyekar CS, Otterstetter R et al. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int. J. Pharm. 234(1–2), 159–167 (2002).
  Medline CASGoogle Scholar
• 14. Russell MA, Merriman R, Stapleton J, Taylor W. Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. Br. Med. J. (Clin. Res. Ed.) 287(6407), 1782–1785 (1983).
  Medline CASGoogle Scholar
• 15. Vaidya A, Mitragotri S. Ionic liquid-mediated delivery of insulin to buccal mucosa. J. Control. Rel. 327, 26–34 (2020).
  Medline CASGoogle Scholar
• 16. Chinna Reddy P, Chaitanya KSC, Madhusudan Rao Y. A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods. Daru 19(6), 385 (2011).
  Medline CASGoogle Scholar
• 17. Bayer IS. Recent advances in mucoadhesive interface materials, mucoadhesion characterization, and technologies. Adv. Mater. Interfaces 9(18), (2022) (Online). •• Gives valuable insight on mucoadhesion.
  Google Scholar
• 18. Tran PHL, Duan W, Tran TTD. Recent developments of nanoparticle-delivered dosage forms for buccal delivery. Int. J. Pharm. 571, doi: 10.1016/j.ijpharm.2019.118697 (2019) (Online).
  MedlineGoogle Scholar
• 19. Manikkath J, Parekh HS, Mutalik S. Surface-engineered nanoliposomes with lipidated and non-lipidated peptide-dendrimeric scaffold for efficient transdermal delivery of a therapeutic agent: development, characterization, toxicological and preclinical performance analyses. Eur. J. Pharm. Biopharm. 156, 97–113 (2020).
  Medline CASGoogle Scholar
• 20. Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J. Control. Rel. 166(1), 10–21 (2013).
  Medline CASGoogle Scholar
• 21. Brizuela M, Winters R. Histology, oral mucosa. Updated 8 May 2023. In: StatPearls. StatPearls Publishing, FL, USA (2023). www.ncbi.nlm.nih.gov/books/NBK572115/
  Google Scholar
• 22. Yakubov GE, Gibbins H, Proctor GB, Carpenter GH. Oral mucosa: physiological and physicochemical aspects. In: Mucoadhesive Materials and Drug Delivery Systems. Khutoryanskiy VV (Ed.). John Wiley and Sons, Chichester, UK, 1–38 (2014).
  Google Scholar
• 23. Schwartz M, Neiers F, Charles JP et al. Oral enzymatic detoxification system: insights obtained from proteome analysis to understand its potential impact on aroma metabolization. Compr. Rev. Food Sci. Food Saf. 20(6), 5516–5547 (2021).
  Medline CASGoogle Scholar
• 24. Sneha R, Vedha Hari BN, Ramya Devi D. Design of antiretroviral drug-polymeric nanoparticles laden buccal films for chronic HIV therapy in paediatrics. Colloid Interface Sci. Commun. 27, 49–59 (2018).
  CASGoogle Scholar
• 25. Zhao K, Xie Y, Lin X, Xu W. The mucoadhesive nanoparticle-based delivery system in the development of mucosal vaccines. Int. J. Nanomed. 17, 4579–4598 (2022).
  Medline CASGoogle Scholar
• 26. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv. Drug Deliv. Rev. 57(11), 1556–1568 (2005).
  Medline CASGoogle Scholar
• 27. Shaikh R, Raj Singh TR, Garland M, Woolfson A, Donnelly R. Mucoadhesive drug delivery systems. J. Pharm. Bioallied Sci. 3(1), 89–100 (2011).
  Medline CASGoogle Scholar
• 28. Brooks AE. The potential of silk and silk-like proteins as natural mucoadhesive biopolymers for controlled drug delivery. Front. Chem. 3, 65 (2015).
  MedlineGoogle Scholar
• 29. Ponchel G, Irache JM. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34(2–3), 191–219 (1998).
  Medline CASGoogle Scholar
• 30. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 61(2), 158–171 (2009).
  Medline CASGoogle Scholar
• 31. Roy S, Pal K, Anis A, Pramanik K, Prabhakar B. Polymers in mucoadhesive drug-delivery systems: a brief note. Des. Monomers Polym. 12(6), 483–495 (2012).
  Google Scholar
• 32. Cone RA. Barrier properties of mucus. Adv. Drug Deliv. Rev. 61(2), 75–85 (2009).
  Medline CASGoogle Scholar
• 33. Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys. J. 81(4), 1930–1937 (2001).
  Medline CASGoogle Scholar
• 34. Saltzman WM, Radomsky ML, Whaley KJ, Cone RA. Antibody diffusion in human cervical mucus. Biophys. J. 66, 508–515 (1994).
  Medline CASGoogle Scholar
• 35. Tan YL, Liu CG. Preparation and characterization of self-assembled nanoparticles based on folic acid modified carboxymethyl chitosan. J. Mater. Sci. Mater. Med. 22(5), 1213–1220 (2011).
  Medline CASGoogle Scholar
• 36. Manikkath J, Sumathy T, Manikkath A, Mutalik S. Delving deeper into dermal and transdermal drug delivery: factors and mechanisms associated with nanocarrier-mediated strategies. Curr. Pharm. Des. 24(27), 3210–3222 (2018). • Gives insight into the biological interaction of nanoparticulate carriers based on their physicochemical properties.
  Medline CASGoogle Scholar
• 37. Hua S, de Matos MBC, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Front. Pharmacol. 9, 790 (2018).
  MedlineGoogle Scholar
• 38. Gómez-Guillén MC, Montero MP. Enhancement of oral bioavailability of natural compounds and probiotics by mucoadhesive tailored biopolymer-based nanoparticles: a review. Food Hydrocoll. 118, doi: 10.1016/j.foodhyd.2021.106772 (2021) (Online).
  Google Scholar
• 39. Mansuri S, Kesharwani P, Jain K, Tekade RK, Jain NK. Mucoadhesion: a promising approach in drug delivery system. React. Funct. Polym. 100, 151–172 (2016).
  CASGoogle Scholar
• 40. Crater JS, Carrier RL. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol. Biosci. 10(12), 1473–1483 (2010).
  Medline CASGoogle Scholar
• 41. Roblegg E, Fröhlich E, Meindl C, Teubl B, Zaversky M, Zimmer A. Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology 6(4), 399–413 (2012).
  Medline CASGoogle Scholar
• 42. Bashyal S, Seo JE, Keum T, Noh G, Lamichhane S, Lee S. Development, characterization, and ex vivo assessment of elastic liposomes for enhancing the buccal delivery of insulin. Pharmaceutics 13(4) (2021).
  MedlineGoogle Scholar
• 43. Smistad G, Jacobsen J, Sande SA. Multivariate toxicity screening of liposomal formulations on a human buccal cell line. Int. J. Pharm. 330(1–2), 14–22 (2007).
  Medline CASGoogle Scholar
• 44. Okafor NI, Ngoepe M, Noundou XS, Maçedo Krause RW. Nano-enabled liposomal mucoadhesive films for enhanced efavirenz buccal drug delivery. J. Drug Deliv. Sci. Technol. 54, doi: 10.1016/j.jddst.2019.101312 (2019) (Online).
  Google Scholar
• 45. Zewail MB, F Asaad G, Swellam SM et al. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation. Int. J. Pharm. 624, doi: 10.1016/j.ijpharm.2022.122006 (2022) (Online).
  MedlineGoogle Scholar
• 46. Tzanova MM, Hagesaether E, Tho I. Solid lipid nanoparticle-loaded mucoadhesive buccal films – critical quality attributes and in vitro safety and efficacy. Int. J. Pharm. 592, doi: 10.1016/j.ijpharm.2020.120100 (2021) (Online).
  MedlineGoogle Scholar
• 47. Kraisit P, Hirun N, Mahadlek J, Limmatvapirat S. Fluconazole-loaded solid lipid nanoparticles (SLNs) as a potential carrier for buccal drug delivery of oral candidiasis treatment using the Box–Behnken design. J. Drug Deliv. Sci. Technol. 63, doi: 10.1016/j.jddst.2021.102437 (2021) (Online).
  Google Scholar
• 48. Ho HN, Le HH, Le TG et al. Formulation and characterization of hydroxyethyl cellulose-based gel containing metronidazole-loaded solid lipid nanoparticles for buccal mucosal drug delivery. Int. J. Biol. Macromol. 194, 1010–1018 (2022).
  Medline CASGoogle Scholar
• 49. Jeitler R, Glader C, Tetyczka C et al. Investigation of cellular interactions of lipid-structured nanoparticles with oral mucosal epithelial cells. Front. Mol. Biosci. 9, doi: 10.3389/fmolb.2022.917921 (2022) (Online).
  MedlineGoogle Scholar
• 50. Rahbarian M, Mortazavian E, Dorkoosh FA, Rafiee Tehrani M. Preparation, evaluation and optimization of nanoparticles composed of thiolated triethyl chitosan: a potential approach for buccal delivery of insulin. J. Drug Deliv. Sci. Technol. 44, 254–263 (2018).
  CASGoogle Scholar
• 51. Amin MK, Boateng JS. Enhancing stability and mucoadhesive properties of chitosan nanoparticles by surface modification with sodium alginate and polyethylene glycol for potential oral mucosa vaccine delivery. Mar. Drugs 20(3), 156 (2022).
  Medline CASGoogle Scholar
• 52. Al-Nemrawi NK, Alsharif SSM, Alzoubi KH, Alkhatib RQ. Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films. Pharm. Dev. Technol. 24(8), 967–974 (2019).
  Medline CASGoogle Scholar
• 53. Suh JW, Lee JS, Ko S, Lee HG. Preparation and characterization of mucoadhesive buccal nanoparticles using chitosan and dextran sulfate. J. Agric. Food Chem. 64(26), 5384–5388 (2016).
  Medline CASGoogle Scholar
• 54. Goldberg M, Manzi A, Conway P et al. A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer. Nat. Commun. 13(1), 1–14 (2022).
  MedlineGoogle Scholar
• 55. Giovino C, Ayensu I, Tetteh J, Boateng JS. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Int. J. Pharm. 428(1–2), 143–151 (2012).
  Medline CASGoogle Scholar
• 56. Giovino C, Ayensu I, Tetteh J, Boateng JS. An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles. Colloids Surf. B Biointerfaces 112, 9–15 (2013).
  Medline CASGoogle Scholar
• 57. Ho HN, Nguyen VAT, Ho NAT, Le HH. Development of a hydrogel containing metronidazole-loaded Eudragit RS 100 nanoparticles for buccal drug delivery. Trop. J. Pharm. Res. 22(6), 1147–1154 (2023).
  CASGoogle Scholar
• 58. Castro PM, Baptista P, Madureira AR, Sarmento B, Pintado ME. Combination of PLGA nanoparticles with mucoadhesive guar-gum films for buccal delivery of antihypertensive peptide. Int. J. Pharm. 547(1–2), 593–601 (2018).
  Medline CASGoogle Scholar
• 59. Castro PM, Baptista P, Zuccheri G, Madureira AR, Sarmento B, Pintado ME. Film-nanoparticle composite for enhanced oral delivery of alpha-casozepine. Colloids Surf. B Biointerfaces 181, 149–157 (2019).
  Medline CASGoogle Scholar
• 60. Castro PM, Sousa F, Magalhães R et al. Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules. Carbohydr. Polym. 194, 411–421 (2018).
  Medline CASGoogle Scholar
• 61. Liang H, Huang Q, Zhou B et al. Self-assembled zein–sodium carboxymethyl cellulose nanoparticles as an effective drug carrier and transporter. J. Mater. Chem. B 3(16), 3242–3253 (2015).
  Medline CASGoogle Scholar
• 62. Wang K, Liu T, Lin R et al. Preparation and in vitro release of buccal tablets of naringenin-loaded MPEG-PCL nanoparticles. RSC Adv. 4(64), 33672–33679 (2014).
  CASGoogle Scholar
• 63. Rodrigues DA, Miguel SP, Loureiro J, Ribeiro M, Roque F, Coutinho P. Oromucosal alginate films with zein nanoparticles as a novel delivery system for digoxin. Pharmaceutics 13(12), 2030 (2021).
  Medline CASGoogle Scholar
• 64. Mašek J, Lubasová D, Lukáč R et al. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles – important step towards effective mucosal vaccines. J. Control. Rel. 249, 183–195 (2017).
  Medline CASGoogle Scholar
• 65. Hashem HM, Motawea A, Kamel AH, Bary EMA, Hassan SSM. Fabrication and characterization of electrospun nanofibers using biocompatible polymers for the sustained release of venlafaxine. Sci. Rep. 12(1), 1–16 (2022).
  MedlineGoogle Scholar
• 66. Zhou L, Li A, Wang H, Sun W, Zuo S, Li C. Preparation and characterization of luteolin-loaded MPEG-PCL-g-PEI micelles for oral Candida albicans infection. J. Drug Deliv. Sci. Technol. 63, doi: 10.1016/j.jddst.2021.102454 (2021) (Online).
  Google Scholar
• 67. de Souza Ferreira SB, Braga G, de Oliveira ÉL et al. Colloidal systems composed of poloxamer 407, different acrylic acid derivatives and curcuminoids: optimization of preparation method, type of bioadhesive polymer and storage conditions. J. Drug Deliv. Sci. Technol. 57, doi: 10.1016/j.jddst.2020.101686 (2020) (Online).
  Google Scholar
• 68. Ouellette M, Masse F, Lefebvre-Demers M et al. Insights into gold nanoparticles as a mucoadhesive system. Sci. Rep. 8(1), 1–15 (2018).
  Medline CASGoogle Scholar
• 69. Essawy MM, El-Sheikh SM, Raslan HS et al. Function of gold nanoparticles in oral cancer beyond drug delivery: implications in cell apoptosis. Oral Dis. 27(2), 251–265 (2021).
  MedlineGoogle Scholar
• 70. Wang S, Jiang L, Meng S et al. Hollow mesoporous silica nanoparticles-loaded ion-crosslinked bilayer films with excellent mechanical properties and high bioavailability for buccal delivery. Int. J. Pharm. 624, doi: 10.1016/j.ijpharm.2022.122056 (2022) (Online).
  Google Scholar
• 71. Yuan Q, Fu Y, Kao WJ, Janigro D, Yang H. Transbuccal delivery of CNS therapeutic nanoparticles: synthesis, characterization, and in vitro permeation studies. ACS Chem. Neurosci. 2(11), 676–683 (2011).
  Medline CASGoogle Scholar
• 72. Lai SK, O'Hanlon DE, Harrold S et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl Acad. Sci. USA 104(5), 1482–1487 (2007).
  Medline CASGoogle Scholar
• 73. Schuster BS, Ensign LM, Allan DB, Suk JS, Hanes J. Particle tracking in drug and gene delivery research: state-of-the-art applications and methods. Adv. Drug. Deliv. Rev. 91, 70–91 (2015).
  Medline CASGoogle Scholar
• 74. McCarron PA, Donnelly RF, Canning PE, McGovern JG, Jones DS. Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis. Biomaterials 25(12), 2399–2407 (2004).
  Medline CASGoogle Scholar
• 75. Rao S, Song Y, Peddie F, Evans AM. Particle size reduction to the nanometer range: a promising approach to improve buccal absorption of poorly water-soluble drugs. Int. J. Nanomed. 6, 1245–1251 (2011).
  Medline CASGoogle Scholar
• 76. Ourique AF, Pohlmann AR, Guterres SS, Beck RCR. Tretinoin-loaded nanocapsules: preparation, physicochemical characterization, and photostability study. Int. J. Pharm. 352(1–2), 1–4 (2008).
  Medline CASGoogle Scholar
• 77. Morales JO, Huang S, Williams RO, McConville JT. Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery. Colloids Surf. B Biointerfaces 122, 38–45 (2014).
  Medline CASGoogle Scholar
• 78. Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur. J. Pharm. Biopharm. 77(2), 187–199 (2011).
  Medline CASGoogle Scholar
• 79. Salehi S, Boddohi S. New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate. Prog. Biomater. 6(4), 175–187 (2017).
  Medline CASGoogle Scholar
• 80. Boateng J, Mani J, Kianfar F. Improving drug loading of mucosal solvent cast films using a combination of hydrophilic polymers with amoxicillin and paracetamol as model drugs. Biomed. Res. Int. 2013 (2013).
  MedlineGoogle Scholar
• 81. Silva BMA, Borges AF, Silva C, Coelho JFJ, Simões S. Mucoadhesive oral films: the potential for unmet needs. Int. J. Pharm. 494(1), 537–551 (2015).
  Medline CASGoogle Scholar
• 82. Shah RB, Patel M, Maahs DM, Shah VN. Insulin delivery methods: past, present and future. Int. J. Pharm. Investig. 6(1), 1 (2016).
  MedlineGoogle Scholar
• 83. Bashir S, Fitaihi R, Abdelhakim HE. Advances in formulation and manufacturing strategies for the delivery of therapeutic proteins and peptides in orally disintegrating dosage forms. Eur. J. Pharm. Sci. 182 (2023).
  MedlineGoogle Scholar
• 84. Nagai T, Machida Y. Buccal delivery systems using hydrogels. Adv. Drug Deliv. Rev. 11(1–2), 179–191 (1993).
  CASGoogle Scholar
• 85. Russo E, Selmin F, Baldassari S et al. A focus on mucoadhesive polymers and their application in buccal dosage forms. J. Drug Deliv. Sci. Technol. 32, 113–125 (2016).
  CASGoogle Scholar
• 86. Singh B, Pal L. Radiation crosslinking polymerization of sterculia polysaccharide–PVA–PVP for making hydrogel wound dressings. Int. J. Biol. Macromol. 48(3), 501–510 (2011).
  Medline CASGoogle Scholar
• 87. Mahmoud GA, Ali AEH, Raafat AI, Badawy NA, Elshahawy MF. Development of (acrylic acid/polyethylene glycol)-zinc oxide mucoadhesive nanocomposites for buccal administration of propranolol HCl. Radiat. Phys. Chem. Oxf. 147, 18–26 (2018).
  CASGoogle Scholar
• 88. El-Hag Ali A, Alarifi AS. Swelling and drug release profile of poly(2-ethyl-2-oxazoline)-based hydrogels prepared by gamma radiation-induced copolymerization. J. Appl. Polym. Sci. 120(5), 3071–3077 (2011).
  Google Scholar
• 89. Hearnden V, Sankar V, Hull K et al. New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv. Drug Deliv. Rev. 64(1), 16–28 (2012).
  Medline CASGoogle Scholar
• 90. Fini A, Bergamante V, Ceschel GC. Mucoadhesive gels designed for the controlled release of chlorhexidine in the oral cavity. Pharmaceutics 3(4), 665–679 (2011).
  Medline CASGoogle Scholar
• 91. Cook SL, Bull SP, Methven L, Parker JK, Khutoryanskiy VV. Mucoadhesion: a food perspective. Food Hydrocoll. 72, 281–296 (2017).
  CASGoogle Scholar
• 92. Ashri LY, Abou El Ela AESF, Ibrahim MA, Alshora DH, Naguib MJ. Optimization and evaluation of chitosan buccal films containing tenoxicam for treating chronic periodontitis: in vitro and in vivo studies. J. Drug Deliv. Sci. Technol. 57, doi: 10.1016/j.jddst.2020.101720 (2020) (Online).
  Google Scholar
• 93. Hirpara MR, Manikkath J, Sivakumar K et al. Long circulating PEGylated-chitosan nanoparticles of rosuvastatin calcium: development and in vitro and in vivo evaluations. Int. J. Biol. Macromol. 107(Pt B), 2190–2200 (2018).
  Medline CASGoogle Scholar
• 94. Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153(1), 41–50 (1997).
  CASGoogle Scholar
• 95. Mahdizadeh Barzoki Z, Emam-Djomeh Z, Mortazavian E et al. Determination of diffusion coefficient for released nanoparticles from developed gelatin/chitosan bilayered buccal films. Int. J. Biol. Macromol. 112, 1005–1013 (2018).
  MedlineGoogle Scholar
• 96. Mortazavian E, Amini M, Dorkoosh FA et al. Preparation, design for optimization and in vitro evaluation of insulin nanoparticles integrating thiolated chitosan derivatives. J. Drug Deliv. Sci. Technol. 24(1), 40–49 (2014).
  CASGoogle Scholar
• 97. Abdelhaleem Ali AM, Abo El-Enin HA. In-vitro/in-vivo evaluation of paclitaxel freeze-dried micellar nanoparticles intended for buccal delivery. J. Drug Deliv. Sci. Technol. 62, doi: 10.1016/j.jddst.2021.102424 (2021) (Online).
  Google Scholar
• 98. Lv Q, Shen C, Li X et al. Mucoadhesive buccal films containing phospholipid-bile salts-mixed micelles as an effective carrier for cucurbitacin B delivery. Drug Deliv. 22(3), 351–358 (2015).
  Medline CASGoogle Scholar
• 99. Gavin A, Pham JT, Wang D, Brownlow B, Elbayoumi TA. Layered nanoemulsions as mucoadhesive buccal systems for controlled delivery of oral cancer therapeutics. Int. J. Nanomed. 10(1), 1569–1584 (2015).
  Medline CASGoogle Scholar
• 100. Itin C, Komargodski R, Domb AJ, Hoffman A. Controlled delivery of apomorphine through buccal mucosa, towards a noninvasive administration method in Parkinson's disease: a preclinical mechanistic study. J. Pharm. Sci. 109(9), 2729–2734 (2020).
  Medline CASGoogle Scholar
• 101. Dong Z, Lin Y, Xu S et al. NIR-triggered tea polyphenol-modified gold nanoparticles-loaded hydrogel treats periodontitis by inhibiting bacteria and inducing bone regeneration. Mater. Des. 225, doi: 10.1016/j.matdes.2022.111487 (2023) (Online).
  Google Scholar
• 102. Rana P, Murthy RSR. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism. Drug Deliv. 20(5), 224–235 (2013).
  Medline CASGoogle Scholar
• 103. Dhanuthai K, Rojanawatsirivej S, Thosaporn W et al. Oral cancer: a multicenter study. Med. Oral Patol. Oral Cir. Bucal. 23(1), e23–e29 (2018).
  Medline CASGoogle Scholar
• 104. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Primers 6(1), 1–22 (2020).
  MedlineGoogle Scholar
• 105. Anand U, Dey A, Chandel AKS et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 10(4), 1367–1401 (2022).
  MedlineGoogle Scholar
• 106. Moorthi C, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J. Pharm. Pharm. Sci. 14(1), 67–77 (2011).
  MedlineGoogle Scholar
• 107. Manikkath J, Jishnu PV, Wich PR, Manikkath A, Radhakrishnan R. Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine (Lond.) 17(3), 181–195 (2022).
  CASGoogle Scholar
• 108. Elsayed A, Al-Remawi M, Jaber N, Abu-Salah KM. Advances in buccal and oral delivery of insulin. Int. J. Pharm. 633 (2023).
  MedlineGoogle Scholar
• 109. Banerjee A, Ibsen K, Brown T, Chen R, Agatemor C, Mitragotri S. Ionic liquids for oral insulin delivery. Proc. Natl Acad. Sci. USA 115(28), 7296–7301 (2018).
  Medline CASGoogle Scholar
• 110. Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat. Rev. Immunol. 21(7), 426–440 (2021).
  Medline CASGoogle Scholar
• 111. Kitamoto S, Nagao-Kitamoto H, Jiao Y et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis. Cell 182(2), 447–462.e14 (2020).
  Medline CASGoogle Scholar